NOFAZINLIMAB
UNII 42T48Q7A6O

Substance Identification & Data

This profile provides standardized clinical and technical data for Nofazinlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 42T48Q7A6O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2377845-98-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

42T48Q7A6O

CAS Registry Number

2377845-98-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NOFAZINLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156726

National Cancer Institute reference terminology for clinical and research data.

INN ID

11892

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nofazinlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NOFAZINLIMAB

Common Names & Synonyms

ANTIBODY CS1003

IMMUNOGLOBULIN G4 (223-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL CS1003 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CS1003 .KAPPA.-CHAIN, DIMER

NOFAZINLIMAB [INN]

NOFAZINLIMAB [WHO-DD]

RECOMBINANT PD-1 MAB CS1003